Kenya assesses mpox preparedness

Kenya is currently facing challenges in its preparedness for handling the growing threat of an Mpox outbreak, with the Permanent Health Secretary reassuring Kenyans that everything is under control. The African CDC has declared Mpox a public health emergency, with approximately 4,000 cases reported so far. Dr. Sam Thenya, Founder & Group CEO of Nairobi Women’s Hospital, expressed concerns regarding the country’s readiness to tackle the outbreak during an interview with CNBC Africa. Despite efforts to implement thermos, scanners, and surveillance at entry points, Dr. Thenya highlighted gaps in preparedness, particularly citing a recent Mpox case in the town of Gilgil where the infected individual had come into contact with numerous people before being diagnosed. The incubation period for Mpox poses a significant challenge, with implications for potential widespread transmission. Dr. Thenya emphasized the need for improved information dissemination and engagement with the private sector to bolster the healthcare response. He raised concerns about the lack of resources dedicated to addressing Mpox, noting that public hospitals have primarily been involved in setting up isolation wards, while private and faith-based facilities have not been adequately engaged. With limited resources and a lack of comprehensive collaboration, Dr. Thenya underscored the urgency for proactive measures to prevent Mpox from escalating into a global pandemic. The interview also touched on the role of health insurance in combating Mpox, with Dr. Thenya highlighting the importance of insurance providers in supporting public health initiatives. However, the absence of universal health coverage in Africa presents a significant barrier to accessing necessary care and treatment. Dr. Thenya called for greater investment from both the private sector and businesses in disseminating accurate information and promoting preventative measures. He emphasized the critical need for collaboration and preparedness to mitigate the potential impact of Mpox on African economies already reeling from the effects of the COVID-19 pandemic. As Mpox continues to pose a threat to public health, Dr. Thenya's insights serve as a wake-up call for stakeholders to prioritize effective response strategies and strengthen healthcare systems to confront this emerging challenge.